The use of opioid receptor agonists and antagonists in the treatment of patients with advanced chronic kidney disease and undergoing renal replacement therapy

Q4 Medicine

Palliative Medicine in Practice Pub Date : 2022-12-28 DOI:10.5603/pmpi.a2022.0019

A. Sołtysik, M. Graczyk, J. Woroń

引用次数: 0

Abstract

The basic principles of pharmacotherapy and changes in pharmacokinetics of drugs in this patient group are discussed in another article: Sołtysik A, Graczyk M, Woroń J. Use of opioid analgesics in chronic kidney disease. Palliat Med Pract 2022; 16(3): 156–166; DOI:

查看原文本刊更多论文

阿片受体激动剂和拮抗剂在晚期慢性肾脏疾病和接受肾脏替代治疗患者中的应用

Sołtysik A、Graczyk M、WorońJ.在另一篇文章中讨论了药物治疗的基本原理和该患者组药物动力学的变化。2022年姑息医学实践；16（3）:156-166；DOI：

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊